FDA Unveils New Biosimilars Q&A
The U.S. Food and Drug Administration on Tuesday floated new question-and-answer guidance regarding various policies for approving biosimilars, elaborating on standards described three years ago and fleshing out other concepts for...To view the full article, register now.
Already a subscriber? Click here to view full article